Skip to main content

Additional Articles by the Author

Drug Updates, Payers' Guide

Otezla (Apremilast), an Oral PDE-4 Inhibitor, Receives FDA Approval for the Treatment of Patients with Active Psoriatic Arthritis and Plaque Psoriasis

Drug Updates, Payers' Guide

Sivextro (Tedizolid Phosphate) Approved for the Treatment of Adults with Acute Bacterial Skin and Skin- Structure Infections

Drug Updates, Payers' Guide

Tanzeum (Albiglutide): A Once-Weekly GLP-1 Receptor Agonist Subcutaneous Injection Approved for the Treatment of Patients with Type 2 Diabetes

Drug Updates, Payers' Guide

Trulicity (Dulaglutide): A New GLP-1 Receptor Agonist Once-Weekly Subcutaneous Injection Approved for the Treatment of Patients with Type 2 Diabetes

Drug Updates, Payers' Guide

Zontivity (Vorapaxar), First-in-Class PAR-1 Antagonist, Receives FDA Approval for Risk Reduction of Heart Attack, Stroke, and Cardiovascular Death

Drug Updates, Payers' Guide

Lenvima (Lenvatinib), a Multireceptor Tyrosine Kinase Inhibitor, Approved by the FDA for the Treatment of Patients with Differentiated Thyroid Cancer

Amitiza (Lubiprostone): The First Oral Treatment Approved by the FDA for Opioid-Induced Constipation

Botox (OnabotulinumtoxinA) Now FDA Approved for Overactive Bladder

Breo Ellipta (Fluticasone Furoate/Vilanterol): Fixed-Dose Combination Oral Inhaler Receives FDA Approval for Long-Term Maintenance Treatment of COPD

Brintellix Tablets (Vortioxetine) Approved by the FDA for the Treatment of Major Depressive Disorder

4
5
6
7
8
9
10

Page 7 of 10
Results 61 - 70 of 98